Journal article
Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe
Roche Diabetes Care GmbH1
Helmholtz Zentrum München - German Research Center for Environmental Health2
German Center for Diabetes Research3
Region Sjælland4
Profil5
EIT Health Germany6
Department of Health Technology, Technical University of Denmark7
Digital Health, Department of Health Technology, Technical University of Denmark8
Personalized Health Technology, Digital Health, Department of Health Technology, Technical University of Denmark9
Department of Applied Mathematics and Computer Science, Technical University of Denmark10
Cognitive Systems, Department of Applied Mathematics and Computer Science, Technical University of Denmark11
University of Copenhagen12
Novo Nordisk Foundation13
Research Centre for Prevention and Health14
...and 4 moreType 2 diabetes mellitus represents a multi-dimensional challenge for European and global societies alike. Building on an iterative six-step disease management process that leverages feedback loops and utilizes commodity digital tools, the PDM-ProValue study program demonstrated that integrated personalized diabetes management, or iPDM, can improve the standard of care for persons living with diabetes in a sustainable way.
The novel “iPDM Goes Europe” consortium strives to advance iPDM adoption by (1) implementing the concept in a value-based healthcare setting for the treatment of persons living with type 2 diabetes, (2) providing tools to assess the patient's physical and mental health status, and (3) exploring new avenues to take advantage of emerging big data resources.
Language: | English |
---|---|
Year: | 2021 |
Pages: | 360-364 |
ISSN: | 18780210 and 17519918 |
Types: | Journal article |
DOI: | 10.1016/j.pcd.2020.10.008 |
ORCIDs: | Bækgaard, Per , Cramer-Petersen, Claus Lundgaard , 0000-0002-5850-2367 , 0000-0002-6008-8628 , 0000-0002-8599-6868 , 0000-0002-8232-9971 , 0000-0003-3397-1308 , 0000-0002-0018-6963 and Bardram, Jakob Eyvind |